Trump Administration's Bold Move to Equalize Drug Prices Hits International Stage
Published on: Aug. 7, 2025, 3:34 p.m. | Source: Devdiscourse
The Trump administration is negotiating with drugmakers to raise European drug prices to lower prescription costs in the U.S. They propose 'most favored nation' pricing, matching U.S. prices to those in other wealthy nations. This strategy faces resistance due to potential impacts on research and development.
